A. Artykov

发表

Detection of staphylococcal enterotoxin a by phage display mediated immuno-PCR method

A. O. Shepelyakovskaya, F. Brovko, S. Zavriev, 2017, Russian Journal of Bioorganic Chemistry.

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL

D. Dolgikh, M. Kirpichnikov, D. Trushina, 2021, Frontiers in Cell and Developmental Biology.

Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity

D. Dolgikh, M. Kirpichnikov, A. Artykov, 2022, International journal of molecular sciences.

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile

D. Dolgikh, M. Kirpichnikov, M. Vorontsova, 2020, Translational oncology.

A New Efficient Method for Production of Recombinant Antitumor Cytokine TRAIL and Its Receptor-Selective Variant DR5-B

D. Dolgikh, M. Kirpichnikov, A. Artykov, 2019, Biochemistry (Moscow).

Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli

Alina Isakova, D. Dolgikh, A. Artykov, 2022, Molecular Biotechnology.

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma

D. Dolgikh, M. Kirpichnikov, M. Pavlyukov, 2022, International journal of molecular sciences.

Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli

D. Dolgikh, A. Artykov, M. Gasparian, 2022, Molecular Biotechnology.

Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells

D. Bagrov, V. Oleinikov, D. Dolgikh, 2021, Pharmaceutics.

A New Efficient Method for Production of Recombinant Antitumor Cytokine TRAIL and Its Receptor-Selective Variant DR5-B

D. Dolgikh, M. Kirpichnikov, A. Artykov, 2019, Biochemistry (Moscow).

ONC201-Induced Mitochondrial Dysfunction, Senescence-like Phenotype, and Sensitization of Cultured BT474 Human Breast Cancer Cells to TRAIL

I. Beletsky, V. Galat, E. Holmuhamedov, 2022, International journal of molecular sciences.

Detection of staphylococcal enterotoxin a by phage display mediated immuno-PCR method

A. O. Shepelyakovskaya, F. Brovko, S. Zavriev, 2017, Russian Journal of Bioorganic Chemistry.

Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesis.

A. Artykov, M. Gasparian, A. V. Yagolovich, 2023, International journal of biological macromolecules.